MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry


Por: Godino, C, Munafo, A, Scotti, A, Estevez-Loureiro, R, Hernandez, AP, Arzamendi, D, Peregrina, EF, Taramasso, M, Fam, NP, Ho, EC, Asgar, A, Vitrella, G, Raineri, C, Adamo, M, Fiorina, C, Montalto, C, Fraccaro, C, Giannini, C, Fiorelli, F, Rubbio, AP, Ooms, JF, Compagnone, M, Maffeo, D, Bettari, L, Furholz, M, Tamburino, C, Petronio, AS, Grasso, C, Agricola, E, Van Mieghem, NM, Tarantini, G, Curello, S, Praz, F, Pascual, I, Potena, L, Colombo, A, Maisano, F, Metra, M, Margonato, A, Crimi, G, Saia, F

Publicada: 1 dic 2020
Resumen:
BACKGROUND: Patients awaiting heart transplantation (HTx) often need bridging therapies to reduce worsening and progression of underlying disease. Limited data are available regarding the use of the MitraClip procedure in secondary mitral regurgitation for this clinical condition. METHODS: We evaluated an international, multicenter (17 centers) registry including 119 patients (median age: 58 years) with moderate-to-severe or severe secondary mitral regurgitation and advanced heart failure (HF) (median left ventricular ejection fraction: 26%) treated with MitraClip as a bridge strategy according to 1 of the following criteria: (1) patients active on HTx list (in list group) (n = 31); (2) patients suitable for HTx but awaiting clinical decision (bridge to decision group) (n = 54); or (3) patients not yet suitable for HTx because of potentially reversible relative contraindications (bridge to candidacy group) (n = 34). RESULTS: Procedural success was achieved in 87.5% of cases, and 30-day survival was 100%. At 1 year, Kaplan-Meier estimates of freedom from the composite primary end-point (death, urgent HTx or left ventricular assist device implantation, first rehospitalization for HF) was 64%. At the time of last available follow-up (median: 532 days), 15% of patients underwent elective transplant, 15.5% remained or could be included in the HTx waiting list, and 23.5% had no more indication to HTx because of clinical improvement. CONCLUSIONS: MitraClip procedure as a bridge strategy to HTx in patients with advanced HF with significant mitral regurgitation was safe, and two thirds of patients remained free from adverse events at 1 year. These findings should be considered exploratory and hypothesis-generating to guide further study for percutaneous intervention in high-risk patients with advanced HF. (C) 2020 International Society for Heart and Lung Transplantation. All rights reserved.

Filiaciones:
Godino, C:
 Ist Sci San Raffaele, Cardio Thorac Vasc Dept, Milan, Italy

Munafo, A:
 Ist Sci San Raffaele, Cardio Thorac Vasc Dept, Milan, Italy

Scotti, A:
 Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Med Sch, Padua, Italy

Estevez-Loureiro, R:
 Univ Hosp Puerta Hierro Majadahonda, Dept Cardiol, Madrid, Spain

Hernandez, AP:
 Univ Hosp Puerta Hierro Majadahonda, Dept Cardiol, Madrid, Spain

Arzamendi, D:
 Univ Autonoma Barcelona, Intment Cardiol Unit, Hosp Santa Creu & St Pau, Cardiol Dept, Barcelona, Spain

Peregrina, EF:
 Univ Autonoma Barcelona, Intment Cardiol Unit, Hosp Santa Creu & St Pau, Cardiol Dept, Barcelona, Spain

Taramasso, M:
 Univ Zurich, Univ Hosp Zurich, Clin Heart & Vasc Surg, Zurich, Switzerland

Fam, NP:
 St Michaels Hosp, Div Cardiol, Toronto, ON, Canada

Ho, EC:
 St Michaels Hosp, Div Cardiol, Toronto, ON, Canada

Asgar, A:
 Univ Montreal, Intervent Cardiol Unit, Montreal Heart Inst, Montreal, PQ, Canada

Vitrella, G:
 Azienda Sanitaria Univ Integrata Trieste, Cardiovasc Dept, Trieste, Italy

Raineri, C:
 Fdn IRCCS Policlin San Matteo Fdn, Div Cardiol, Pavia, Italy

Adamo, M:
 Spedali Civili Brescia, Catheterizat Lab, Cardiothorac Dept, Brescia, Italy

Fiorina, C:
 Spedali Civili Brescia, Catheterizat Lab, Cardiothorac Dept, Brescia, Italy

Montalto, C:
 Fdn IRCCS Policlin San Matteo Fdn, Div Cardiol, Pavia, Italy

Fraccaro, C:
 Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Med Sch, Padua, Italy

Giannini, C:
 Univ Pisa, Dept Anesthesia & Intens Care, Cardiac Thorac & Vasc Dept, Pisa, Italy

Fiorelli, F:
 Univ Pisa, Dept Anesthesia & Intens Care, Cardiac Thorac & Vasc Dept, Pisa, Italy

Rubbio, AP:
 Azienda Ospedaliero Univ Policlin Vittorio Emanue, Div Cardiol, Cardio Thorac Vasc Dept, Catania, Italy

Ooms, JF:
 Erasmus MC, Dept Cardiol Thoraxctr, Rotterdam, Netherlands

Compagnone, M:
 Univ Hosp Bologna, Cardio Thoraco Vasc Dept, Cardiol Unit, Policlin S Orsola Malpighi, Bologna, Italy

Maffeo, D:
 Fdn Poliambulanza Ist Ospedaliero, Cardiovasc Dept, Brescia, Italy

Bettari, L:
 Fdn Poliambulanza Ist Ospedaliero, Cardiovasc Dept, Brescia, Italy

Furholz, M:
 Univ Bern, Bern Univ Hosp Inselspital, Dept Cardiol, Bern, Switzerland

Tamburino, C:
 Azienda Ospedaliero Univ Policlin Vittorio Emanue, Div Cardiol, Cardio Thorac Vasc Dept, Catania, Italy

Petronio, AS:
 Univ Pisa, Dept Anesthesia & Intens Care, Cardiac Thorac & Vasc Dept, Pisa, Italy

Grasso, C:
 Azienda Ospedaliero Univ Policlin Vittorio Emanue, Div Cardiol, Cardio Thorac Vasc Dept, Catania, Italy

Agricola, E:
 Ist Sci San Raffaele, Cardio Thorac Vasc Dept, Milan, Italy

Van Mieghem, NM:
 Erasmus MC, Dept Cardiol Thoraxctr, Rotterdam, Netherlands

Tarantini, G:
 Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Med Sch, Padua, Italy

Curello, S:
 Spedali Civili Brescia, Catheterizat Lab, Cardiothorac Dept, Brescia, Italy

Praz, F:
 Univ Bern, Bern Univ Hosp Inselspital, Dept Cardiol, Bern, Switzerland

Pascual, I:
 Hosp Univ Cent Asturias HUCA, Intervent Cardiol Unit, Oviedo, Spain

Potena, L:
 Univ Hosp Bologna, Cardio Thoraco Vasc Dept, Cardiol Unit, Policlin S Orsola Malpighi, Bologna, Italy

Colombo, A:
 Ist Sci San Raffaele, Cardio Thorac Vasc Dept, Milan, Italy

Maisano, F:
 Univ Zurich, Univ Hosp Zurich, Clin Heart & Vasc Surg, Zurich, Switzerland

Metra, M:
 Spedali Civili Brescia, Catheterizat Lab, Cardiothorac Dept, Brescia, Italy

Margonato, A:
 Ist Sci San Raffaele, Cardio Thorac Vasc Dept, Milan, Italy

Crimi, G:
 Univ Genoa, Intervent Cardiol Unit, Cardio Thoraco Vasc Dept DICATOV, AOU San Martino IST,IRCCS, Genoa, Italy

Saia, F:
 Univ Hosp Bologna, Cardio Thoraco Vasc Dept, Cardiol Unit, Policlin S Orsola Malpighi, Bologna, Italy
ISSN: 10532498





JOURNAL OF HEART AND LUNG TRANSPLANTATION
Editorial
ELSEVIER SCIENCE INC, STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 39 Número: 12
Páginas: 1353-1362
WOS Id: 000595157100005
ID de PubMed: 33008726
imagen Bronze

MÉTRICAS